LifeVantage Corporation — Form 10-Q Summary
Reporting period: Fiscal third quarter and nine months ended March 31, 2021, compared with the same periods in 2020. The request metadata says “2020 Q3,” but the filing is for the quarter ended March 31, 2021 (fiscal 2021 Q3). Amounts below are U.S. dollars; financial figures are in millions unless noted.
Financial performance
| Metric | Three months ended March 31 | Nine months ended March 31 |
|---|---|---|
| Revenue | $51.6 (2020: $56.1), down 8.0% | $165.4 (2020: $173.5), down 4.7% |
| Gross profit / margin | $42.8 / 82.9% (2020: $47.0 / 83.8%) | $137.0 / 82.8% (2020: $145.0 / 83.6%) |
| Operating income | $2.1 (2020: $3.0) | $11.0 (2020: $9.3) |
| Net income | $1.7 (2020: $1.7); diluted EPS $0.12 (2020: $0.11) | $8.0 (2020: $7.7); diluted EPS $0.55 (2020: $0.53) |
| Operating cash flow | Not separately presented | $7.9 (2020: $9.0) |
For the quarter, lower revenue and gross profit were partly offset by lower operating expenses; operating income declined while net income was slightly higher, helped by lower income tax expense. For the nine months, operating income and net income improved despite lower revenue, alongside reduced operating expenses. Gross margin fell in both comparisons, which management attributed to higher shipping costs, fewer event-related fees, and changes in geographic and product mix.
Revenue trends and material changes
- Americas revenue declined 9.4% for the quarter and 6.2% for the nine-month period. Management cited fewer active accounts and the prior-year launch-related sales contribution from Protandim NAD Synergizer; current-period Daily Wellness sales and virtual events partly offset the quarterly decline.
- Asia/Pacific & Europe revenue declined 4.7% for the quarter and 1.0% for the nine months. Australia and New Zealand grew, while Greater China weakened. Japan revenue was down 6.3% and 3.5% on a constant-currency basis, respectively.
- Total active accounts fell 4.0% year over year to 168,000; active distributors declined 4.5% and active customers declined 3.7%.
- Foreign exchange positively affected reported revenue by $0.9 million for the quarter and $1.8 million for the nine months. Approximately 34% of nine-month revenue was generated outside the United States.
Cash, debt, and capital resources
- Cash and cash equivalents were $19.0 million at March 31, 2021, down from $22.1 million at June 30, 2020. Working capital was $21.3 million, compared with $18.8 million at fiscal year-end.
- Nine-month investing cash use was $3.3 million, primarily property and equipment purchases. Financing cash use was $7.8 million, including $8.0 million of share repurchases.
- The company had repaid the remaining balance of its term loan in fiscal 2020. It reported a revolving credit facility of up to $5.0 million; the filing text does not provide a clear outstanding revolver balance.
- On April 1, 2021, after quarter-end, the credit facility maturity was extended to March 31, 2024. The amended facility has a variable rate based on the one-month U.S. Treasury rate plus 3.00%, subject to a 4.00% floor, and revised financial covenants. The company said it was covenant-compliant at March 31.
- Operating lease liabilities totaled $17.8 million at March 31. The company reported no off-balance-sheet arrangements and said cash and operating cash flow should cover requirements for at least 12 months.
Outlook, risks, and unusual items
- Management planned to focus on distributor and customer enrollment and retention, subscription and loyalty programs, product and market launches, and distributor tools. It expected commissions as a percentage of revenue to fluctuate slightly and SG&A as a percentage of revenue to remain steady for the rest of fiscal 2021; no specific revenue or earnings guidance was provided.
- COVID-19 continued to disrupt in-person recruiting, events, showrooms, and distributor activity. Management also cited possible supply, delivery, employee, and customer-spending impacts, and said the overall effects remained uncertain.
- The company recorded $0.8 million of expense during the nine months for abandonment of its former Sandy, Utah office lease and related assets. It opened a new Lehi, Utah corporate office in January 2021.
- The Smith v. LifeVantage class action retained a securities claim after other claims were dismissed. The company recorded no loss accrual because it viewed liability as not probable or estimable, but warned an unfavorable outcome could materially affect the business.
- Management identified distributor retention and compliance, product acceptance and concentration, supply-chain and inventory management, international and currency exposure, regulation, litigation, cyber and IT risks, and credit-facility covenants among relevant risks. It reported disclosure controls were effective and no material change in internal control during the quarter.
Important facts for investors to verify
- Confirm the filing period: quarter ended March 31, 2021, rather than “2020 Q3” in the request metadata.
- Track whether declining Americas revenue and active-account counts stabilize, and whether growth in Australia and New Zealand offsets weakness in Greater China and other markets.
- Review the April 1 credit amendment, covenant definitions and compliance headroom, and confirm any revolver borrowings.
- Monitor cash generation against repurchases, capital expenditures, lease commitments, and other operating obligations.
- Follow developments in the Smith litigation and assess potential exposure, which the filing does not quantify.